Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997–2002)
- 31 January 2006
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 27 (1) , 69-72
- https://doi.org/10.1016/j.ijantimicag.2005.09.011
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997–2002)Diagnostic Microbiology and Infectious Disease, 2005
- Appropriate antimicrobial treatment in nosocomial infections—the clinical challengesJournal of Hospital Infection, 2003
- The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997–2000Clinical Microbiology & Infection, 2003
- Sustained activity and spectrum of selected extended-spectrum β-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997–2000)International Journal of Antimicrobial Agents, 2003
- Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 2002
- Determining the value of antimicrobial surveillance programsDiagnostic Microbiology and Infectious Disease, 2001
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- The MYSTIC (meropenem yearly susceptibility test information collection) programmeInternational Journal of Antimicrobial Agents, 1999